Dose optimization of dasatinib in chronic-phase chronic myeloid leukemia: A systematic review and meta-analysis of 50 mg versus 100 mg once daily

Abdulgayoom M et al. Clin Lymphoma Myelom Leuk, September 2026

• Share
• Tweet
• Share
• Share